Clinical Trials
11 trialsNCT04681417 2025-11-28
RETINO 2018
Institut Curie
Phase 2/3 Recruiting
NCT00186888 2025-09-04
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
St. Jude Children's Research Hospital
Phase 3 Completed
NCT06972602 2025-05-15
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1 Recruiting
NCT01783535 2024-04-16
Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT04455139 2023-10-03
EuRbG2018
University of Lausanne Hospitals
Phase 2 Terminated
NCT04799002 2021-03-16
Topotecan and Melphalan for Retinoblastoma
Sun Yat-sen University
Phase 3 Recruiting
NCT02390843 2020-04-03
AflacST1402
Emory University
Phase 1 Completed
NCT00980551 2017-03-03
RELRB1
Children's Hospital Medical Center, Cincinnati
Phase NA Withdrawn
NCT00002515 2013-06-24
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00004006 2011-10-04
Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
St. Jude Children's Research Hospital
Phase 2 Completed
NCT00460876 2008-05-02
Phase I Trial of Periocular Topotecan in Retinoblastoma
Hospital JP Garrahan
Phase 1 Completed